Innovative startup in Biotechnology, LPS-BioSciences is specialized in bacterial endotoxins. LPS-BioSciences provides services, products and research, to help companies from human and animal health with managing endotoxins issues. Our fields of applications include vaccine industry, in vitro diagnostic, cosmetic, and medical device. 

Our goal is to make endotoxins accessible for the pharmaceutical industry and to offer a consistent range of services and developments to meet the needs associated with endotoxins. 


Boost-LPS platform

LPS-BioSciences develops tomorrow's adjuvants using bacterial endotoxins as powerful activators of the immune system.


Our Partners

LPS-Biosciences is supported by



Our Services

  • Fast-LPS

    Giving you access to the quantity of LPS material you need, extracted from your own bacterial strain at the quality level you want.

  • Target-LPS

    Giving you access to the best LPS-antigens candidates for designing your vaccines and diagnostic tests with best immunogenic results.

  • Remov-LPS

    Giving you access to the best way to quantify and remove Endotoxins contaminants from your therapeutic production.





Latest News


LPS-BIOSCIENCES invited Bruno LEMAITRE for a conference in Orsay on March 15th, 2017 Aude BRETON successfully defended her thesis in Orsay on February 28th.  LPS-BIOSCENCES participated to the TechInnov Funding meetingsJean-Marc CAVAILLON presents a new MOOC on Innate Immunity